adenosine monophosphate has been researched along with Pulmonary Fibrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, L; Lu, Y; Wang, Q; Wei, T; Wu, M; Wu, Z; Yan, Q; Zhan, T; Zhang, W | 1 |
| Di Perri, G | 1 |
| Lu, YB; Tian, YX; Wang, Q; Wu, M; Wu, ZX; Zhan, TW; Zhang, WP | 1 |
3 other study(ies) available for adenosine monophosphate and Pulmonary Fibrosis
| Article | Year |
|---|---|
Cangrelor alleviates bleomycin-induced pulmonary fibrosis by inhibiting platelet activation in mice.
Topics: Adenosine Monophosphate; Animals; Bleomycin; CD40 Antigens; Cytokines; Disease Models, Animal; Inflammation Mediators; Lung; Male; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Neutrophils; Platelet Activation; Platelet Aggregation Inhibitors; Pulmonary Fibrosis | 2020 |
The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection
Topics: Adenosine Monophosphate; Alanine; Anticoagulants; Antiviral Agents; Biomarkers; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Disease Management; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Embolism; Endothelium, Vascular; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Interferon beta-1b; Lopinavir; Macrophage Activation; Pandemics; Pneumonia, Viral; Pulmonary Fibrosis; Randomized Controlled Trials as Topic; Ritonavir; Thromboembolism; Thrombophilia; Thrombosis | 2020 |
Cangrelor alleviates pulmonary fibrosis by inhibiting GPR17-mediated inflammation in mice.
Topics: Adenosine Monophosphate; Animals; Bleomycin; Cell Survival; Dose-Response Relationship, Drug; Inflammation; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Pulmonary Fibrosis; RAW 264.7 Cells; Receptors, G-Protein-Coupled; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2018 |